Sign Up Today and Learn More About Olaris Stock
Invest in or calculate the value of your shares in Olaris or other pre-IPO companies through EquityZen's platform.
Olaris Stock
Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning
About Olaris Stock
Founded
2013
Headquarters
Framingham, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Olaris Press Mentions
Stay in the know about the latest news on Olaris
Olaris Announces Clinical Study Demonstrating the Utility of myOLARIS-KTdx Urine Test to Detect and Differentiate Kidney Graft Injury
prweb • Sep 09, 2025
Olaris to Present Results from Three Studies Showcasing Non-Invasive Urine Assays for Graft Injury Detection and Drug Compliance at 2025 World Transplant Congress
prweb • Aug 03, 2025
Polaris Schedules Second Quarter 2025 Earnings Conference Call and Webcast
prnewswire • Jun 26, 2025
Polaris Schedules Second Quarter 2025 Earnings Conference Call and Webcast
marketscreener • Jun 26, 2025
Polaris Donates $1 Million to Advance ATV and UTV Safety Through 4-H Youth Development
prnewswire • Jun 12, 2025
Olaris Management
Leadership team at Olaris
Chief Commercial and Operations Officer
Laura Housman
CTO & Scientific Advisory Board Member
Mahantesh Kothiwale
Join now and verify your accreditation status to gain access to:
- Olaris Current Valuation
- Olaris Stock Price
- Olaris Management
- Available deals in Olaris and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Olaris Cap Table and Funding History by Share Class and Liquidity Preferences
- Olaris Revenue and Financials
- Olaris Highlights
- Olaris Business Model
- Olaris Risk Factors
- Olaris Research Report from SACRA Research
Trading Olaris Stock
How to invest in Olaris stock?
Accredited investors can buy pre-IPO stock in companies like Olaris through EquityZen funds. These investments are made available by existing Olaris shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Olaris stock?
Shareholders can sell their Olaris stock through EquityZen's private company marketplace. EquityZen's network includes over 390K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 48K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."